Global Interventional Oncology Device Market Growth 2021-2026

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Oncology Device Consumption 2016-2026
2.1.2 Interventional Oncology Device Consumption CAGR by Region
2.2 Interventional Oncology Device Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Supporting Devices
2.2.4 Next Generation Devices
2.3 Interventional Oncology Device Sales by Type
2.3.1 Global Interventional Oncology Device Sales Market Share by Type (2016-2021)
2.3.2 Global Interventional Oncology Device Revenue and Market Share by Type (2016-2021)
2.3.3 Global Interventional Oncology Device Sale Price by Type (2016-2021)
2.4 Interventional Oncology Device Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics and Ambulatory Surgical Centers
2.4.3 Others (Homecare and Research Institutes)
2.5 Interventional Oncology Device Sales by Application
2.5.1 Global Interventional Oncology Device Sale Market Share by Application (2016-2021)
2.5.2 Global Interventional Oncology Device Revenue and Market Share by Application (2016-2021)
2.5.3 Global Interventional Oncology Device Sale Price by Application (2016-2021)

3 Global Interventional Oncology Device by Company
3.1 Global Interventional Oncology Device Sales Market Share by Company
3.1.1 Global Interventional Oncology Device Sales by Company (2019-2021)
3.1.2 Global Interventional Oncology Device Sales Market Share by Company (2019-2021)
3.2 Global Interventional Oncology Device Revenue Market Share by Company
3.2.1 Global Interventional Oncology Device Revenue by Company (2019-2021)
3.2.2 Global Interventional Oncology Device Revenue Market Share by Company (2019-2021)
3.3 Global Interventional Oncology Device Sale Price by Company
3.4 Global Manufacturers Interventional Oncology Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Oncology Device Product Location Distribution
3.4.2 Players Interventional Oncology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Interventional Oncology Device by Region
4.1 Global Interventional Oncology Device by Region
4.1.1 Global Interventional Oncology Device Sales by Region
4.1.2 Global Interventional Oncology Device Revenue by Region
4.2 Americas Interventional Oncology Device Sales Growth
4.3 APAC Interventional Oncology Device Sales Growth
4.4 Europe Interventional Oncology Device Sales Growth
4.5 Middle East & Africa Interventional Oncology Device Sales Growth

5 Americas
5.1 Americas Interventional Oncology Device Sales by Country
5.1.1 Americas Interventional Oncology Device Sales by Country (2016-2021)
5.1.2 Americas Interventional Oncology Device Revenue by Country (2016-2021)
5.2 Americas Interventional Oncology Device Sales by Type
5.3 Americas Interventional Oncology Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Interventional Oncology Device Sales by Region
6.1.1 APAC Interventional Oncology Device Sales by Region (2016-2021)
6.1.2 APAC Interventional Oncology Device Revenue by Region (2016-2021)
6.2 APAC Interventional Oncology Device Sales by Type
6.3 APAC Interventional Oncology Device Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Interventional Oncology Device by Country
7.1.1 Europe Interventional Oncology Device Sales by Country (2016-2021)
7.1.2 Europe Interventional Oncology Device Revenue by Country (2016-2021)
7.2 Europe Interventional Oncology Device Sales by Type
7.3 Europe Interventional Oncology Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Interventional Oncology Device by Country
8.1.1 Middle East & Africa Interventional Oncology Device Sales by Country (2016-2021)
8.1.2 Middle East & Africa Interventional Oncology Device Revenue by Country (2016-2021)
8.2 Middle East & Africa Interventional Oncology Device Sales by Type
8.3 Middle East & Africa Interventional Oncology Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Interventional Oncology Device Distributors
10.3 Interventional Oncology Device Customer

11 Global Interventional Oncology Device Market Forecast
11.1 Global Interventional Oncology Device Forecast by Region
11.1.1 Global Interventional Oncology Device Forecast by Regions (2021-2026)
11.2.2 Global Interventional Oncology Device Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Interventional Oncology Device Forecast by Type
11.7 Global Interventional Oncology Device Forecast by Application

12 Key Players Analysis
12.1 AngioDynamics, Inc.
12.1.1 AngioDynamics, Inc. Company Information
12.1.2 AngioDynamics, Inc. Interventional Oncology Device Product Offered
12.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AngioDynamics, Inc. Main Business Overview
12.1.5 AngioDynamics, Inc. Latest Developments
12.2 BD
12.2.1 BD Company Information
12.2.2 BD Interventional Oncology Device Product Offered
12.2.3 BD Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 BD Main Business Overview
12.2.5 BD Latest Developments
12.3 Boston Scientific Corporation
12.3.1 Boston Scientific Corporation Company Information
12.3.2 Boston Scientific Corporation Interventional Oncology Device Product Offered
12.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Boston Scientific Corporation Main Business Overview
12.3.5 Boston Scientific Corporation Latest Developments
12.4 BTG Plc
12.4.1 BTG Plc Company Information
12.4.2 BTG Plc Interventional Oncology Device Product Offered
12.4.3 BTG Plc Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 BTG Plc Main Business Overview
12.4.5 BTG Plc Latest Developments
12.5 Eckert & Ziegler BEBIG
12.5.1 Eckert & Ziegler BEBIG Company Information
12.5.2 Eckert & Ziegler BEBIG Interventional Oncology Device Product Offered
12.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Eckert & Ziegler BEBIG Main Business Overview
12.5.5 Eckert & Ziegler BEBIG Latest Developments
12.6 HealthTronics, Inc.
12.6.1 HealthTronics, Inc. Company Information
12.6.2 HealthTronics, Inc. Interventional Oncology Device Product Offered
12.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 HealthTronics, Inc. Main Business Overview
12.6.5 HealthTronics, Inc. Latest Developments
12.7 IceCure Medical
12.7.1 IceCure Medical Company Information
12.7.2 IceCure Medical Interventional Oncology Device Product Offered
12.7.3 IceCure Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 IceCure Medical Main Business Overview
12.7.5 IceCure Medical Latest Developments
12.8 Medtronic PLC
12.8.1 Medtronic PLC Company Information
12.8.2 Medtronic PLC Interventional Oncology Device Product Offered
12.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Medtronic PLC Main Business Overview
12.8.5 Medtronic PLC Latest Developments
12.9 Medwaves, Inc.
12.9.1 Medwaves, Inc. Company Information
12.9.2 Medwaves, Inc. Interventional Oncology Device Product Offered
12.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Medwaves, Inc. Main Business Overview
12.9.5 Medwaves, Inc. Latest Developments
12.10 Merit Medical Systems, Inc.
12.10.1 Merit Medical Systems, Inc. Company Information
12.10.2 Merit Medical Systems, Inc. Interventional Oncology Device Product Offered
12.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Merit Medical Systems, Inc. Main Business Overview
12.10.5 Merit Medical Systems, Inc. Latest Developments
12.11 Sanarus Technologies, Inc.
12.11.1 Sanarus Technologies, Inc. Company Information
12.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Product Offered
12.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Sanarus Technologies, Inc. Main Business Overview
12.11.5 Sanarus Technologies, Inc. Latest Developments
12.12 Sirtex Medical Ltd.
12.12.1 Sirtex Medical Ltd. Company Information
12.12.2 Sirtex Medical Ltd. Interventional Oncology Device Product Offered
12.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Sirtex Medical Ltd. Main Business Overview
12.12.5 Sirtex Medical Ltd. Latest Developments
12.13 Sonacare Medical
12.13.1 Sonacare Medical Company Information
12.13.2 Sonacare Medical Interventional Oncology Device Product Offered
12.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Sonacare Medical Main Business Overview
12.13.5 Sonacare Medical Latest Developments
12.14 Terumo Corporation
12.14.1 Terumo Corporation Company Information
12.14.2 Terumo Corporation Interventional Oncology Device Product Offered
12.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Terumo Corporation Main Business Overview
12.14.5 Terumo Corporation Latest Developments
12.15 Trod Medical
12.15.1 Trod Medical Company Information
12.15.2 Trod Medical Interventional Oncology Device Product Offered
12.15.3 Trod Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Trod Medical Main Business Overview
12.15.5 Trod Medical Latest Developments
12.16 Cook Meidical LLC
12.16.1 Cook Meidical LLC Company Information
12.16.2 Cook Meidical LLC Interventional Oncology Device Product Offered
12.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Cook Meidical LLC Main Business Overview
12.16.5 Cook Meidical LLC Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Interventional Oncology Device Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Ablation Devices
Table 3. Major Players of Embolization Devices
Table 4. Major Players of Supporting Devices
Table 5. Major Players of Next Generation Devices
Table 6. Global Interventional Oncology Device Sales by Type (2016-2021) & (K Units)
Table 7. Global Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 8. Global Interventional Oncology Device Revenue by Type (2016-2021) & ($ million)
Table 9. Global Interventional Oncology Device Revenue Market Share by Type (2016-2021)
Table 10. Global Interventional Oncology Device Sale Price by Type (2016-2021)
Table 11. Global Interventional Oncology Device Sales by Application (2016-2021) & (K Units)
Table 12. Global Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 13. Global Interventional Oncology Device Value by Application (2016-2021)
Table 14. Global Interventional Oncology Device Revenue Market Share by Application (2016-2021)
Table 15. Global Interventional Oncology Device Sale Price by Application (2016-2021)
Table 16. Global Interventional Oncology Device Sales by Company (2019-2021) & (K Units)
Table 17. Global Interventional Oncology Device Sales Market Share by Company (2019-2021)
Table 18. Global Interventional Oncology Device Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Interventional Oncology Device Revenue Market Share by Company (2019-2021)
Table 20. Global Interventional Oncology Device Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Interventional Oncology Device Producing Area Distribution and Sales Area
Table 22. Players Interventional Oncology Device Products Offered
Table 23. Interventional Oncology Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Interventional Oncology Device Sales by Region (2016-2021) (K Units)
Table 27. Global Interventional Oncology Device Sales Market Share by Region (2016-2021)
Table 28. Global Interventional Oncology Device Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Interventional Oncology Device Revenue Market Share by Region (2016-2021)
Table 30. Americas Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 31. Americas Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 32. Americas Interventional Oncology Device Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 34. Americas Interventional Oncology Device Sales by Type (2016-2021) & (K Units)
Table 35. Americas Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 36. Americas Interventional Oncology Device Sales by Application (2016-2021) & (K Units)
Table 37. Americas Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 38. APAC Interventional Oncology Device Sales by Region (2016-2021) & (K Units)
Table 39. APAC Interventional Oncology Device Sales Market Share by Region (2016-2021)
Table 40. APAC Interventional Oncology Device Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Interventional Oncology Device Revenue Market Share by Region (2016-2021)
Table 42. APAC Interventional Oncology Device Sales by Type (2016-2021) & (K Units)
Table 43. APAC Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 44. APAC Interventional Oncology Device Sales by Application (2016-2021) & (K Units)
Table 45. APAC Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 46. Europe Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 47. Europe Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 48. Europe Interventional Oncology Device Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 50. Europe Interventional Oncology Device Sales by Type (2016-2021) & (K Units)
Table 51. Europe Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 52. Europe Interventional Oncology Device Sales by Application (2016-2021) & (K Units)
Table 53. Europe Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Interventional Oncology Device Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Interventional Oncology Device Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Interventional Oncology Device Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Interventional Oncology Device
Table 63. Key Application and Potential Industries of Interventional Oncology Device
Table 64. Key Challenges of Interventional Oncology Device
Table 65. Key Trends of Interventional Oncology Device
Table 66. Interventional Oncology Device Distributors List
Table 67. Interventional Oncology Device Customer List
Table 68. Global Interventional Oncology Device Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Interventional Oncology Device Consumption Market Forecast by Region
Table 70. Global Interventional Oncology Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Interventional Oncology Device Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Interventional Oncology Device Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Interventional Oncology Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Interventional Oncology Device Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Interventional Oncology Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Interventional Oncology Device Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Interventional Oncology Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Interventional Oncology Device Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Interventional Oncology Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Interventional Oncology Device Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Interventional Oncology Device Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Interventional Oncology Device Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Interventional Oncology Device Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Interventional Oncology Device Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Interventional Oncology Device Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Interventional Oncology Device Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Interventional Oncology Device Revenue Market Share Forecast by Application (2021-2026)
Table 88. AngioDynamics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 89. AngioDynamics, Inc. Interventional Oncology Device Product Offered
Table 90. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. AngioDynamics, Inc. Main Business
Table 92. AngioDynamics, Inc. Latest Developments
Table 93. BD Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 94. BD Interventional Oncology Device Product Offered
Table 95. BD Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. BD Main Business
Table 97. BD Latest Developments
Table 98. Boston Scientific Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Corporation Interventional Oncology Device Product Offered
Table 100. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Boston Scientific Corporation Main Business
Table 102. Boston Scientific Corporation Latest Developments
Table 103. BTG Plc Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 104. BTG Plc Interventional Oncology Device Product Offered
Table 105. BTG Plc Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. BTG Plc Main Business
Table 107. BTG Plc Latest Developments
Table 108. Eckert & Ziegler BEBIG Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Eckert & Ziegler BEBIG Interventional Oncology Device Product Offered
Table 110. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Eckert & Ziegler BEBIG Main Business
Table 112. Eckert & Ziegler BEBIG Latest Developments
Table 113. HealthTronics, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 114. HealthTronics, Inc. Interventional Oncology Device Product Offered
Table 115. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. HealthTronics, Inc. Main Business
Table 117. HealthTronics, Inc. Latest Developments
Table 118. IceCure Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 119. IceCure Medical Interventional Oncology Device Product Offered
Table 120. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. IceCure Medical Main Business
Table 122. IceCure Medical Latest Developments
Table 123. Medtronic PLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Medtronic PLC Interventional Oncology Device Product Offered
Table 125. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Medtronic PLC Main Business
Table 127. Medtronic PLC Latest Developments
Table 128. Medwaves, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Medwaves, Inc. Interventional Oncology Device Product Offered
Table 130. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. Medwaves, Inc. Main Business
Table 132. Medwaves, Inc. Latest Developments
Table 133. Merit Medical Systems, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 134. Merit Medical Systems, Inc. Interventional Oncology Device Product Offered
Table 135. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 136. Merit Medical Systems, Inc. Main Business
Table 137. Merit Medical Systems, Inc. Latest Developments
Table 138. Sanarus Technologies, Inc. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Sanarus Technologies, Inc. Interventional Oncology Device Product Offered
Table 140. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 141. Sanarus Technologies, Inc. Main Business
Table 142. Sanarus Technologies, Inc. Latest Developments
Table 143. Sirtex Medical Ltd. Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Sirtex Medical Ltd. Interventional Oncology Device Product Offered
Table 145. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 146. Sirtex Medical Ltd. Main Business
Table 147. Sirtex Medical Ltd. Latest Developments
Table 148. Sonacare Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 149. Sonacare Medical Interventional Oncology Device Product Offered
Table 150. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 151. Sonacare Medical Main Business
Table 152. Sonacare Medical Latest Developments
Table 153. Terumo Corporation Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 154. Terumo Corporation Interventional Oncology Device Product Offered
Table 155. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 156. Terumo Corporation Main Business
Table 157. Terumo Corporation Latest Developments
Table 158. Trod Medical Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Trod Medical Interventional Oncology Device Product Offered
Table 160. Trod Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 161. Trod Medical Main Business
Table 162. Trod Medical Latest Developments
Table 163. Cook Meidical LLC Basic Information, Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Cook Meidical LLC Interventional Oncology Device Product Offered
Table 165. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 166. Cook Meidical LLC Main Business
Table 167. Cook Meidical LLC Latest Developments
List of Figures
Figure 1. Picture of Interventional Oncology Device
Figure 2. Interventional Oncology Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Oncology Device Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Interventional Oncology Device Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Interventional Oncology Device Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Ablation Devices
Figure 10. Product Picture of Embolization Devices
Figure 11. Product Picture of Supporting Devices
Figure 12. Product Picture of Next Generation Devices
Figure 13. Global Interventional Oncology Device Sales Market Share by Type in 2020
Figure 14. Global Interventional Oncology Device Revenue Market Share by Type (2016-2021)
Figure 15. Interventional Oncology Device Consumed in Hospitals
Figure 16. Global Interventional Oncology Device Market: Hospitals (2016-2021) & (K Units)
Figure 17. Interventional Oncology Device Consumed in Specialty Clinics and Ambulatory Surgical Centers
Figure 18. Global Interventional Oncology Device Market: Specialty Clinics and Ambulatory Surgical Centers (2016-2021) & (K Units)
Figure 19. Interventional Oncology Device Consumed in Others (Homecare and Research Institutes)
Figure 20. Global Interventional Oncology Device Market: Others (Homecare and Research Institutes) (2016-2021) & (K Units)
Figure 21. Global Interventional Oncology Device Sales Market Share by Application (2016-2021)
Figure 22. Global Interventional Oncology Device Revenue Market Share by Application in 2020
Figure 23. Interventional Oncology Device Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Interventional Oncology Device Revenue Market Share by Company in 2020
Figure 25. Global Interventional Oncology Device Sales Market Share by Regions (2016-2021)
Figure 26. Global Interventional Oncology Device Revenue Market Share by Region in 2020
Figure 27. Americas Interventional Oncology Device Sales 2016-2021 (K Units)
Figure 28. Americas Interventional Oncology Device Revenue 2016-2021 ($ Millions)
Figure 29. APAC Interventional Oncology Device Sales 2016-2021 (K Units)
Figure 30. APAC Interventional Oncology Device Revenue 2016-2021 ($ Millions)
Figure 31. Europe Interventional Oncology Device Sales 2016-2021 (K Units)
Figure 32. Europe Interventional Oncology Device Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Interventional Oncology Device Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Interventional Oncology Device Revenue 2016-2021 ($ Millions)
Figure 35. Americas Interventional Oncology Device Sales Market Share by Country in 2020
Figure 36. Americas Interventional Oncology Device Revenue Market Share by Country in 2020
Figure 37. Americas Interventional Oncology Device Sales Market Share by Type in 2020
Figure 38. Americas Interventional Oncology Device Sales Market Share by Application in 2020
Figure 39. United States Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Interventional Oncology Device Sales Market Share by Region in 2020
Figure 44. APAC Interventional Oncology Device Revenue Market Share by Regions in 2020
Figure 45. APAC Interventional Oncology Device Sales Market Share by Type in 2020
Figure 46. APAC Interventional Oncology Device Sales Market Share by Application in 2020
Figure 47. China Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Interventional Oncology Device Sales Market Share by Country in 2020
Figure 54. Europe Interventional Oncology Device Revenue Market Share by Country in 2020
Figure 55. Europe Interventional Oncology Device Sales Market Share by Type in 2020
Figure 56. Europe Interventional Oncology Device Sales Market Share by Application in 2020
Figure 57. Germany Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Interventional Oncology Device Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Interventional Oncology Device Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Interventional Oncology Device Sales Market Share by Application in 2020
Figure 66. Egypt Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Interventional Oncology Device Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.